Research programme: DNA vaccines - Inovio

Drug Profile

Research programme: DNA vaccines - Inovio

Alternative Names: Chikungunya virus DNA vaccine - Inovio; CHIKV vaccine - Inovio; Cytomegalovirus DNA vaccine - Inovio; dMab HIV - Inovio; DNA vaccine against HIV clade C - Inovio; INO 5400; MAGE-A DNA vaccine; Malaria vaccine - Inovio; Smallpox vaccine - Inovio; SynCon WT1 cancer immunotherapy

Latest Information Update: 01 Feb 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Inovio Pharmaceuticals
  • Developer Drexel University College of Medicine; Inovio Pharmaceuticals
  • Class AIDS vaccines; Bacterial vaccines; Cancer vaccines; DNA vaccines; Hepatitis C vaccines; Parasitic vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Smallpox

Highest Development Phases

  • Discontinued Cancer; Chikungunya virus infections; Clostridium-difficile-infections; Cytomegalovirus infections; Human papillomavirus infections; Malaria; Malignant melanoma; Smallpox; Tuberculosis

Most Recent Events

  • 01 Feb 2018 Discontinued - Preclinical for Cancer in USA (Parenteral)
  • 01 Feb 2018 Discontinued - Preclinical for Chikungunya virus infections in USA (IM)
  • 01 Feb 2018 Discontinued - Preclinical for Clostridium difficile infections in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top